Deprescribing Benzodiazepine Receptor Agonists
This clinical practice guideline is intended to help clinicians make decisions about when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs). This guideline applies to patients who are using BZRAs to treat primary insomnia or comorbid insomnia where the potential comorbidities are effectively managed. 13 pages. Last reviewed June 2018.